Page 2 - Vimla Tyagi News Today

Yatharth Hospitals, a leading hospital chain in Delhi-NCR, has opened its initial public offering (IPO) for public subscription. The IPO includes a fresh issue of up to INR 490 crore and an offer for sale of INR 65.51 lakh shares, with a price range of INR 285-300 per share.

Yatharth Hospital: Marquee investors participated in the anchor book included ICICI Prudential, Nippon Life, HDFC Mutual Fund, Aditya Birla Sun Life Trustee, Bandhan Mutual Fund, and HSBC Global Investment Funds.

The initial public offering (IPO) of Yatharth Hospital will open for subscription on July 26. The issue closes on July 28. The companys shares are expected to get listed on both exchanges. Here are 10 things to know about the offer.

Upcoming IPOs launches next week: It will be yet another busy week for the primary market with four public issues getting rolled out for bidding. Check all the IPOs to watch for next week ending July 29, 2023.

Yatharth Hospital will utilise fresh issue proceeds for repaying debts, capital expenditure for hospitals, and funding inorganic growth initiatives, besides general corporate purposes

The Yatharth Hospital and Trauma Care Services IPO comprises a fresh issue of equity shares accumulating up to Rs 490 crore.

Incorporated in 2008, Yatharth Hospital and Trauma Care Services is a multi-care hospital chain, ranked among the top 10 largest private hospitals in the National Capital Region of Delhi.

Yatharth Hospital IPO: Yatharth Hospital’s IPO comprises a fresh issue of equity shares aggregating up to Rs 490 crore and an offer-for-sale (OFS) of up to 65.51 lakh equity shares by the company's promoters, including from its promoters including Vimla Tyagi, Prem Narayan Tyagi and Neena Tyagi and promoter group entities., Markets News, Times Now

Plutus Wealth Management was allotted shares worth Rs 60 crore and Think India Opportunities Master Fund Rs 30 crore. After the pre-IPO placement, fresh issue size has been reduced to Rs 490 crore from Rs 610 crore

The pre-IPO placement was done in consultation with the Book Running Lead Managers (BRLMs) and was approved by the Board at its meeting held on Wednesday July 5, 2023 and by the shareholders at their extraordinary general meeting held on the same day, the exchange filing said.